Report Description Request For TOC Research Methodology Download Free Sample

Market Snapshot

CAGR:9.33

2023

2032

Source: Market Expertz

Study Period	2019-2032
Base Year	2023
Forcast Year	2023-2032
CAGR	9.33

Gain accurate insights regarding the negative impacts of COVID-19 on all markets and industries

Download Sample Pdf

Report Overview

In 2018, the global Bioengineered Proteins Drugs market size was million US$ and it is expected to reach million US$ by the end of 2026, with a CAGR of during 2019-2026.

This report focuses on the global Bioengineered Proteins Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Bioengineered Proteins Drugs development in United States, Europe and China.

The key players covered in this study
Eli Lilly
F. Hoffmann-La Roche
Sanofi
Pfizer
GlaxoSmithKline
Novartis
Allergan
AbbVie
Agilent Technologies
Panacea Biotec
Wockhardt

Market segment by Type, the product can be split into
Cytokines and Chemokines
Monoclonal Antibodies
Therapeutic Enzymes
Peptide Hormones
Peptide Antibiotics
Vaccines
Other

Market segment by Application, split into
Diabetes and Hormonal Disorders
Genetic and Fertility Disorders
Cancers
Organ Transplants
Others

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Bioengineered Proteins Drugs status, future forecast, growth opportunity, key market and key players.
To present the Bioengineered Proteins Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Bioengineered Proteins Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2026
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Bioengineered Proteins Drugs Market Size Growth Rate by Type (2014-2026)
1.4.2 Cytokines and Chemokines
1.4.3 Monoclonal Antibodies
1.4.4 Therapeutic Enzymes
1.4.5 Peptide Hormones
1.4.6 Peptide Antibiotics
1.4.7 Vaccines
1.4.8 Other
1.5 Market by Application
1.5.1 Global Bioengineered Proteins Drugs Market Share by Application (2014-2026)
1.5.2 Diabetes and Hormonal Disorders
1.5.3 Genetic and Fertility Disorders
1.5.4 Cancers
1.5.5 Organ Transplants
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Bioengineered Proteins Drugs Market Size
2.2 Bioengineered Proteins Drugs Growth Trends by Regions
2.2.1 Bioengineered Proteins Drugs Market Size by Regions (2014-2026)
2.2.2 Bioengineered Proteins Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Bioengineered Proteins Drugs Market Size by Manufacturers
3.1.1 Global Bioengineered Proteins Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Bioengineered Proteins Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Bioengineered Proteins Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Bioengineered Proteins Drugs Key Players Head office and Area Served
3.3 Key Players Bioengineered Proteins Drugs Product/Solution/Service
3.4 Date of Enter into Bioengineered Proteins Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Bioengineered Proteins Drugs Market Size by Type (2014-2019)
4.2 Global Bioengineered Proteins Drugs Market Size by Application (2014-2019)

5 United States
5.1 United States Bioengineered Proteins Drugs Market Size (2014-2019)
5.2 Bioengineered Proteins Drugs Key Players in United States
5.3 United States Bioengineered Proteins Drugs Market Size by Type
5.4 United States Bioengineered Proteins Drugs Market Size by Application

6 Europe
6.1 Europe Bioengineered Proteins Drugs Market Size (2014-2019)
6.2 Bioengineered Proteins Drugs Key Players in Europe
6.3 Europe Bioengineered Proteins Drugs Market Size by Type
6.4 Europe Bioengineered Proteins Drugs Market Size by Application

7 China
7.1 China Bioengineered Proteins Drugs Market Size (2014-2019)
7.2 Bioengineered Proteins Drugs Key Players in China
7.3 China Bioengineered Proteins Drugs Market Size by Type
7.4 China Bioengineered Proteins Drugs Market Size by Application

8 Japan
8.1 Japan Bioengineered Proteins Drugs Market Size (2014-2019)
8.2 Bioengineered Proteins Drugs Key Players in Japan
8.3 Japan Bioengineered Proteins Drugs Market Size by Type
8.4 Japan Bioengineered Proteins Drugs Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Bioengineered Proteins Drugs Market Size (2014-2019)
9.2 Bioengineered Proteins Drugs Key Players in Southeast Asia
9.3 Southeast Asia Bioengineered Proteins Drugs Market Size by Type
9.4 Southeast Asia Bioengineered Proteins Drugs Market Size by Application

10 India
10.1 India Bioengineered Proteins Drugs Market Size (2014-2019)
10.2 Bioengineered Proteins Drugs Key Players in India
10.3 India Bioengineered Proteins Drugs Market Size by Type
10.4 India Bioengineered Proteins Drugs Market Size by Application

11 Central & South America
11.1 Central & South America Bioengineered Proteins Drugs Market Size (2014-2019)
11.2 Bioengineered Proteins Drugs Key Players in Central & South America
11.3 Central & South America Bioengineered Proteins Drugs Market Size by Type
11.4 Central & South America Bioengineered Proteins Drugs Market Size by Application

12 International Players Profiles
12.1 Eli Lilly
12.1.1 Eli Lilly Company Details
12.1.2 Company Description and Business Overview
12.1.3 Bioengineered Proteins Drugs Introduction
12.1.4 Eli Lilly Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.1.5 Eli Lilly Recent Development
12.2 F. Hoffmann-La Roche
12.2.1 F. Hoffmann-La Roche Company Details
12.2.2 Company Description and Business Overview
12.2.3 Bioengineered Proteins Drugs Introduction
12.2.4 F. Hoffmann-La Roche Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.2.5 F. Hoffmann-La Roche Recent Development
12.3 Sanofi
12.3.1 Sanofi Company Details
12.3.2 Company Description and Business Overview
12.3.3 Bioengineered Proteins Drugs Introduction
12.3.4 Sanofi Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.3.5 Sanofi Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Bioengineered Proteins Drugs Introduction
12.4.4 Pfizer Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 GlaxoSmithKline
12.5.1 GlaxoSmithKline Company Details
12.5.2 Company Description and Business Overview
12.5.3 Bioengineered Proteins Drugs Introduction
12.5.4 GlaxoSmithKline Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.5.5 GlaxoSmithKline Recent Development
12.6 Novartis
12.6.1 Novartis Company Details
12.6.2 Company Description and Business Overview
12.6.3 Bioengineered Proteins Drugs Introduction
12.6.4 Novartis Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.6.5 Novartis Recent Development
12.7 Allergan
12.7.1 Allergan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Bioengineered Proteins Drugs Introduction
12.7.4 Allergan Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.7.5 Allergan Recent Development
12.8 AbbVie
12.8.1 AbbVie Company Details
12.8.2 Company Description and Business Overview
12.8.3 Bioengineered Proteins Drugs Introduction
12.8.4 AbbVie Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.8.5 AbbVie Recent Development
12.9 Agilent Technologies
12.9.1 Agilent Technologies Company Details
12.9.2 Company Description and Business Overview
12.9.3 Bioengineered Proteins Drugs Introduction
12.9.4 Agilent Technologies Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.9.5 Agilent Technologies Recent Development
12.10 Panacea Biotec
12.10.1 Panacea Biotec Company Details
12.10.2 Company Description and Business Overview
12.10.3 Bioengineered Proteins Drugs Introduction
12.10.4 Panacea Biotec Revenue in Bioengineered Proteins Drugs Business (2014-2019)
12.10.5 Panacea Biotec Recent Development
12.11 Wockhardt

13 Market Forecast 2019-2026
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2026)
13.10 Market Size Forecast by Application (2019-2026)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Bioengineered Proteins Drugs Key Market Segments
Table Key Players Bioengineered Proteins Drugs Covered
Table Global Bioengineered Proteins Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Bioengineered Proteins Drugs Market Size Market Share by Type 2014-2025
Figure Cytokines and Chemokines Figures
Table Key Players of Cytokines and Chemokines
Figure Monoclonal Antibodies Figures
Table Key Players of Monoclonal Antibodies
Figure Therapeutic Enzymes Figures
Table Key Players of Therapeutic Enzymes
Figure Peptide Hormones Figures
Table Key Players of Peptide Hormones
Figure Peptide Antibiotics Figures
Table Key Players of Peptide Antibiotics
Figure Vaccines Figures
Table Key Players of Vaccines
Figure Other Figures
Table Key Players of Other
Table Global Bioengineered Proteins Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Diabetes and Hormonal Disorders Case Studies
Figure Genetic and Fertility Disorders Case Studies
Figure Cancers Case Studies
Figure Organ Transplants Case Studies
Figure Others Case Studies
Figure Bioengineered Proteins Drugs Report Years Considered
Table Global Bioengineered Proteins Drugs Market Size 2014-2025 (Million US$)
Figure Global Bioengineered Proteins Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Bioengineered Proteins Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Bioengineered Proteins Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Bioengineered Proteins Drugs Market Share by Regions 2014-2019
Figure Global Bioengineered Proteins Drugs Market Share by Regions 2014-2019
Figure Global Bioengineered Proteins Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Bioengineered Proteins Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Bioengineered Proteins Drugs Market Share by Manufacturers (2014-2019)
Figure Global Bioengineered Proteins Drugs Market Share by Manufacturers in 2018
Table Global Bioengineered Proteins Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Bioengineered Proteins Drugs Product/Solution/Service
Table Date of Enter into Bioengineered Proteins Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Bioengineered Proteins Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Bioengineered Proteins Drugs Market Size Share by Type (2014-2019)
Figure Global Bioengineered Proteins Drugs Market Size Market Share by Type (2014-2019)
Table Global Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Bioengineered Proteins Drugs Market Size Share by Application (2014-2019)
Figure Global Bioengineered Proteins Drugs Market Size Market Share by Application (2014-2019)
Figure Global Bioengineered Proteins Drugs Revenue Market Share by Application in 2018
Figure United States Bioengineered Proteins Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Bioengineered Proteins Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Bioengineered Proteins Drugs Market Share (2018-2019)
Table United States Bioengineered Proteins Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Bioengineered Proteins Drugs Market Share by Type (2014-2019)
Table United States Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Bioengineered Proteins Drugs Market Share by Application (2014-2019)
Figure Europe Bioengineered Proteins Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Bioengineered Proteins Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Bioengineered Proteins Drugs Market Share (2018-2019)
Table Europe Bioengineered Proteins Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Bioengineered Proteins Drugs Market Share by Type (2014-2019)
Table Europe Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Bioengineered Proteins Drugs Market Share by Application (2014-2019)
Figure China Bioengineered Proteins Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Bioengineered Proteins Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Bioengineered Proteins Drugs Market Share (2018-2019)
Table China Bioengineered Proteins Drugs Market Size by Type (2014-20189) (Million US$)
Table China Bioengineered Proteins Drugs Market Share by Type (2014-2019)
Table China Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table China Bioengineered Proteins Drugs Market Share by Application (2014-2019)
Figure Japan Bioengineered Proteins Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Bioengineered Proteins Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Bioengineered Proteins Drugs Market Share (2018-2019)
Table Japan Bioengineered Proteins Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Bioengineered Proteins Drugs Market Share by Type (2014-2019)
Table Japan Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Bioengineered Proteins Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Bioengineered Proteins Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Bioengineered Proteins Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Bioengineered Proteins Drugs Market Share (2018-2019)
Table Southeast Asia Bioengineered Proteins Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Bioengineered Proteins Drugs Market Share by Type (2014-2019)
Table Southeast Asia Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Bioengineered Proteins Drugs Market Share by Application (2014-2019)
Figure India Bioengineered Proteins Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Bioengineered Proteins Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Bioengineered Proteins Drugs Market Share (2018-2019)
Table India Bioengineered Proteins Drugs Market Size by Type (2014-2019) (Million US$)
Table India Bioengineered Proteins Drugs Market Share by Type (2014-2019)
Table India Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table India Bioengineered Proteins Drugs Market Share by Application (2014-2019)
Figure Central & South America Bioengineered Proteins Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Bioengineered Proteins Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Bioengineered Proteins Drugs Market Share (2018-2019)
Table Central & South America Bioengineered Proteins Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Bioengineered Proteins Drugs Market Share by Type (2014-2019)
Table Central & South America Bioengineered Proteins Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Bioengineered Proteins Drugs Market Share by Application (2014-2019)
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Bioengineered Proteins Drugs Business (2014-2019) (Million US$)
Figure Eli Lilly Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table Eli Lilly Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table F. Hoffmann-La Roche Recent Development
Table Sanofi Company Details
Table Sanofi Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure Sanofi Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table Sanofi Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure Pfizer Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table Novartis Recent Development
Table Allergan Company Details
Table Allergan Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure Allergan Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table Allergan Recent Development
Table AbbVie Company Details
Table AbbVie Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure AbbVie Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table AbbVie Recent Development
Table Agilent Technologies Company Details
Table Agilent Technologies Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure Agilent Technologies Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table Agilent Technologies Recent Development
Table Panacea Biotec Company Details
Table Panacea Biotec Revenue in Bioengineered Proteins Drugs Business (2014-2019)(Million US$)
Figure Panacea Biotec Revenue Growth Rate in Bioengineered Proteins Drugs Business (2014-2019)
Table Panacea Biotec Recent Development
Table Wockhardt Company Details
Table Global Bioengineered Proteins Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Bioengineered Proteins Drugs Market Size Share by Regions (2019-2025)
Figure Global Bioengineered Proteins Drugs Market Size Share by Regions in 2025
Figure United States Bioengineered Proteins Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Bioengineered Proteins Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Bioengineered Proteins Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Bioengineered Proteins Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Bioengineered Proteins Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Bioengineered Proteins Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Bioengineered Proteins Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Bioengineered Proteins Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Bioengineered Proteins Drugs Market Size by Product (2019-2025)
Figure Global Bioengineered Proteins Drugs Market Size by Product in 2025
Table Global Bioengineered Proteins Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Bioengineered Proteins Drugs Market Size by Application (2019-2025)
Figure Global Bioengineered Proteins Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

RESEARCH METHODOLOGY

A research methodology is a systematic approach for assessing or conducting a market study. Researchers tend to draw on a variety of both qualitative and quantitative study methods, inclusive of investigations, survey, secondary data and market observation.

Such plans can focus on classifying the products offered by leading market players or simply use statistical models to interpret observations or test hypotheses. While some methods aim for a detailed description of the factors behind an observation, others present the context of the current market scenario.

Now let’s take a closer look at the research methods here.

Secondary Research Model

Extensive data is obtained and cumulated on a substantial basis during the inception phase of the research process. The data accumulated is consistently filtered through validation from the in-house database, paid sources as well reputable industry magazines. A robust research study requires an understanding of the overall value chain. Annual reports and financials of industry players are studied thoroughly to have a comprehensive idea of the market taxonomy.

Primary Insights

Post conglomeration of the data obtained through secondary research; a validation process is initiated to verify the numbers or figures. This process is usually performed by having a detailed discussion with the industry experts.

However, we do not restrict our primary interviews only to the industry leaders. Our team covers the entire value chain while verifying the data. A significant number of raw material suppliers, local manufacturers, distributors, and stakeholders are interviewed to make our findings authentic. The current trends which include the drivers, restraints, and opportunities are also derived through the primary research process.

Market Estimation

The market estimation is conducted by analyzing the data collected through both secondary and primary research. This process involves market breakdown, bottom-up and top- down approach.

Moreover, while forecasting the market a comprehensive statistical time series model is designed for each market. Macroeconomic indicators are considered to understand the current trends of the market. Each data point is verified by the process of data triangulation method to arrive at the final market estimates.

Final Presentation

The penultimate process results in a holistic research report. The study equips key industry players to undertake significant strategic decisions through the findings. The report encompasses detailed market information. Graphical representations of the current market trends are also made available in order to make the study highly comprehensible for the reader.

You can also purchase parts of this report. Do you want to check out a section wise price list?

Request for Special Pricing

Personalized Business Report Tailored to Your Requirements

Our expert analysts collaborate directly with you to comprehend your specific needs.
Get data on regions, segments, competitors, and vendors of your choice.
Information is presented in alignment with your exact preferences and formatting.

Request for customization

Ask For Discount

Free Sample Report

"Find new revenue generation opportunities"

Bioengineered Proteins Drugs Market Size, Type Analysis, Application Analysis, End-Use, Industry Analysis, Regional Outlook, Competitive Strategies And Forecasts, 2023-2032